Not quite, primaus72, P2b was run against Lucentis monotherapy only. No Eylea arm included back then.
Instead, COAST is the very first time sozinibercept formaly is being tested against Eylea monotherapy
Ann: Security Class Reinstatement to Quotation- OPTOB, page-19
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
82.5¢ |
Change
0.015(1.85%) |
Mkt cap ! $1.015B | |||
| Open | High | Low | Value | Volume |
| 84.5¢ | 84.5¢ | 80.0¢ | $2.835M | 3.473M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 17359 | 82.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 83.0¢ | 106026 | 2 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| OPT (ASX) Chart |